PayPal beats Q1 earnings but stock down 25% YTD amid economic uncertainty and rising competition.
Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.
PayPal beats Q1 earnings but stock down 25% YTD amid economic uncertainty and rising competition.
Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.